Cargando…
P867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH-RISK SUBSETS AND PRELIMINARY GENE SIGNATURE OF DURABLE RESPONSE
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429269/ http://dx.doi.org/10.1097/01.HS9.0000846348.62497.10 |
| _version_ | 1784779387793571840 |
|---|---|
| author | Martin, N. Xu, A. Stong, N. Rytlewski, J. Finney, O. Campbell, T. Pierceall, W. Flynt, E. Thompson, E. Kaiser, S. |
| author_facet | Martin, N. Xu, A. Stong, N. Rytlewski, J. Finney, O. Campbell, T. Pierceall, W. Flynt, E. Thompson, E. Kaiser, S. |
| author_sort | Martin, N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429269 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94292692022-08-31 P867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH-RISK SUBSETS AND PRELIMINARY GENE SIGNATURE OF DURABLE RESPONSE Martin, N. Xu, A. Stong, N. Rytlewski, J. Finney, O. Campbell, T. Pierceall, W. Flynt, E. Thompson, E. Kaiser, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429269/ http://dx.doi.org/10.1097/01.HS9.0000846348.62497.10 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Martin, N. Xu, A. Stong, N. Rytlewski, J. Finney, O. Campbell, T. Pierceall, W. Flynt, E. Thompson, E. Kaiser, S. P867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH-RISK SUBSETS AND PRELIMINARY GENE SIGNATURE OF DURABLE RESPONSE |
| title | P867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH-RISK SUBSETS AND PRELIMINARY GENE SIGNATURE OF DURABLE RESPONSE |
| title_full | P867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH-RISK SUBSETS AND PRELIMINARY GENE SIGNATURE OF DURABLE RESPONSE |
| title_fullStr | P867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH-RISK SUBSETS AND PRELIMINARY GENE SIGNATURE OF DURABLE RESPONSE |
| title_full_unstemmed | P867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH-RISK SUBSETS AND PRELIMINARY GENE SIGNATURE OF DURABLE RESPONSE |
| title_short | P867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH-RISK SUBSETS AND PRELIMINARY GENE SIGNATURE OF DURABLE RESPONSE |
| title_sort | p867: tumor profiling of idecabtagene vicleucel (ide-cel; bb2121) patients in karmma showed comparable responses in existing molecular high-risk subsets and preliminary gene signature of durable response |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429269/ http://dx.doi.org/10.1097/01.HS9.0000846348.62497.10 |
| work_keys_str_mv | AT martinn p867tumorprofilingofidecabtagenevicleucelidecelbb2121patientsinkarmmashowedcomparableresponsesinexistingmolecularhighrisksubsetsandpreliminarygenesignatureofdurableresponse AT xua p867tumorprofilingofidecabtagenevicleucelidecelbb2121patientsinkarmmashowedcomparableresponsesinexistingmolecularhighrisksubsetsandpreliminarygenesignatureofdurableresponse AT stongn p867tumorprofilingofidecabtagenevicleucelidecelbb2121patientsinkarmmashowedcomparableresponsesinexistingmolecularhighrisksubsetsandpreliminarygenesignatureofdurableresponse AT rytlewskij p867tumorprofilingofidecabtagenevicleucelidecelbb2121patientsinkarmmashowedcomparableresponsesinexistingmolecularhighrisksubsetsandpreliminarygenesignatureofdurableresponse AT finneyo p867tumorprofilingofidecabtagenevicleucelidecelbb2121patientsinkarmmashowedcomparableresponsesinexistingmolecularhighrisksubsetsandpreliminarygenesignatureofdurableresponse AT campbellt p867tumorprofilingofidecabtagenevicleucelidecelbb2121patientsinkarmmashowedcomparableresponsesinexistingmolecularhighrisksubsetsandpreliminarygenesignatureofdurableresponse AT pierceallw p867tumorprofilingofidecabtagenevicleucelidecelbb2121patientsinkarmmashowedcomparableresponsesinexistingmolecularhighrisksubsetsandpreliminarygenesignatureofdurableresponse AT flynte p867tumorprofilingofidecabtagenevicleucelidecelbb2121patientsinkarmmashowedcomparableresponsesinexistingmolecularhighrisksubsetsandpreliminarygenesignatureofdurableresponse AT thompsone p867tumorprofilingofidecabtagenevicleucelidecelbb2121patientsinkarmmashowedcomparableresponsesinexistingmolecularhighrisksubsetsandpreliminarygenesignatureofdurableresponse AT kaisers p867tumorprofilingofidecabtagenevicleucelidecelbb2121patientsinkarmmashowedcomparableresponsesinexistingmolecularhighrisksubsetsandpreliminarygenesignatureofdurableresponse |